Atlas Trials

An Observational Cross-sectional Study Evaluating the Sociodemographic and Clinical Characteristics of Patients Diagnosed With NVAF With a Risk of Stroke or Systemic Embolism, Who Are on Treatment to Adequately Control Their Coagulation and Treated in Primary Care Centres

Clinical trial NCT02470767 · COMPLETED

Trial details

NCT number
NCT02470767
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
StrokePrevention and ControlAtrial Fibrillation
Start date
2015-05-01
Primary completion
2015-12-01
Enrollment
792

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.